Form4.ai tracks every SEC insider trade in real time. See every TBPH insider filing with a free account — no card.
See every TBPH insider filing — free account, no card.
Free accountTheravance Biopharma, Inc. (TBPH) has 17 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $227K. Most recent filing: Sept. 28, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 28, 2026 SEC filing | Weiss Asset Management LP Insider | Other | $126,770,020 | — |
| Sep 24, 2026 SEC filing | PAKIANATHAN DEEPIKA Director | Other | — | — |
| Sep 24, 2026 SEC filing | O'Connor Donal Director | Other | — | — |
Create a free account to see all 17 TBPH filings from the last 90 days. No card needed.
Create free accountWant TBPH insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.